Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo

Fuente: Zenodo
Salvato in:
Dettagli Bibliografici
Autori principali: Hoff, Nicole A., Mukadi, Patrick, Doshi, Reena H., Bramble, Matthew S., Lu, Kai, Gadoth, Adva, Sinai, Cyrus, Spencer, D'Andre, Nicholson, Bradley P., Williams, Russell, Mossoko, Matthias, Ilunga-Kebela, Benoit, Wasiswa, Joseph, Okitolonda-Wemakoy, Emile, Alfonso, Vivian H., Steffen, Imke, Muyembe-Tamfum, Jean-Jacques, Simmons, Graham, Rimoin, Anne W.
Natura: Recurso digital
Pubblicazione: Zenodo 2019
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866901704192032768
author Hoff, Nicole A.
Mukadi, Patrick
Doshi, Reena H.
Bramble, Matthew S.
Lu, Kai
Gadoth, Adva
Sinai, Cyrus
Spencer, D'Andre
Nicholson, Bradley P.
Williams, Russell
Mossoko, Matthias
Ilunga-Kebela, Benoit
Wasiswa, Joseph
Okitolonda-Wemakoy, Emile
Alfonso, Vivian H.
Steffen, Imke
Muyembe-Tamfum, Jean-Jacques
Simmons, Graham
Rimoin, Anne W.
author_facet Hoff, Nicole A.
Mukadi, Patrick
Doshi, Reena H.
Bramble, Matthew S.
Lu, Kai
Gadoth, Adva
Sinai, Cyrus
Spencer, D'Andre
Nicholson, Bradley P.
Williams, Russell
Mossoko, Matthias
Ilunga-Kebela, Benoit
Wasiswa, Joseph
Okitolonda-Wemakoy, Emile
Alfonso, Vivian H.
Steffen, Imke
Muyembe-Tamfum, Jean-Jacques
Simmons, Graham
Rimoin, Anne W.
contents (Uploaded by Plazi for the Bat Literature Project) Healthcare settings have played a major role in propagation of Ebola virus (EBOV) outbreaks. Healthcare workers (HCWs) have elevated risk of contact with EBOV-infected patients, particularly if safety precautions are not rigorously practiced. We conducted a serosurvey to determine seroprevalence against multiple EBOV antigens among HCWs of Boende Health Zone, Democratic Republic of the Congo, the site of a 2014 EBOV outbreak. Interviews and specimens were collected from 565 consenting HCWs. Overall, 234 (41.4%) of enrolled HCWs were reactive to at least 1 EBOV protein: 159 (28.1%) were seroreactive for anti-glycoprotein immunoglobulin G (IgG), 89 (15.8%) were seroreactive for anti-nucleoprotein IgG, and 54 (9.5%) were VP40 positive. Additionally, sera from 16 (2.8%) HCWs demonstrated neutralization capacity. These data demonstrate that a significant proportion of HCWs have the ability to neutralize virus, despite never having developed Ebola virus disease symptoms, highlighting an important and poorly documented aspect of EBOV infection and progression.
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_13533203
institution Zenodo
language
publishDate 2019
publisher Zenodo
record_format zenodo
spellingShingle Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo
Hoff, Nicole A.
Mukadi, Patrick
Doshi, Reena H.
Bramble, Matthew S.
Lu, Kai
Gadoth, Adva
Sinai, Cyrus
Spencer, D'Andre
Nicholson, Bradley P.
Williams, Russell
Mossoko, Matthias
Ilunga-Kebela, Benoit
Wasiswa, Joseph
Okitolonda-Wemakoy, Emile
Alfonso, Vivian H.
Steffen, Imke
Muyembe-Tamfum, Jean-Jacques
Simmons, Graham
Rimoin, Anne W.
Adult
Aged
Aged, 80 and over
Antibodies, Neutralizing
Antibodies, Viral
Democratic Republic of the Congo
Ebolavirus
Female
Health Personnel
Humans
Immunoglobulin G
Male
Middle Aged
Seroepidemiologic Studies
Surveys and Questionnaires
Young Adult
Biodiversity
Mammalia
Chiroptera
Chordata
Animalia
bats
bat
(Uploaded by Plazi for the Bat Literature Project) Healthcare settings have played a major role in propagation of Ebola virus (EBOV) outbreaks. Healthcare workers (HCWs) have elevated risk of contact with EBOV-infected patients, particularly if safety precautions are not rigorously practiced. We conducted a serosurvey to determine seroprevalence against multiple EBOV antigens among HCWs of Boende Health Zone, Democratic Republic of the Congo, the site of a 2014 EBOV outbreak. Interviews and specimens were collected from 565 consenting HCWs. Overall, 234 (41.4%) of enrolled HCWs were reactive to at least 1 EBOV protein: 159 (28.1%) were seroreactive for anti-glycoprotein immunoglobulin G (IgG), 89 (15.8%) were seroreactive for anti-nucleoprotein IgG, and 54 (9.5%) were VP40 positive. Additionally, sera from 16 (2.8%) HCWs demonstrated neutralization capacity. These data demonstrate that a significant proportion of HCWs have the ability to neutralize virus, despite never having developed Ebola virus disease symptoms, highlighting an important and poorly documented aspect of EBOV infection and progression.
title Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo
topic Adult
Aged
Aged, 80 and over
Antibodies, Neutralizing
Antibodies, Viral
Democratic Republic of the Congo
Ebolavirus
Female
Health Personnel
Humans
Immunoglobulin G
Male
Middle Aged
Seroepidemiologic Studies
Surveys and Questionnaires
Young Adult
Biodiversity
Mammalia
Chiroptera
Chordata
Animalia
bats
bat
url https://doi.org/10.5281/zenodo.13533203